Results 1 to 10 of about 753 (64)

Thyroid Eye Disease

open access: yesLife, 2022
Thyroid eye disease (TED), an autoimmune inflammatory disorder of the orbit, presents with a potential array of clinical sequelae. The pathophysiology behind TED has been partially characterized in the literature.
Ramy Rashad   +4 more
doaj   +3 more sources

Sphingolipids in thyroid eye disease

open access: yesFrontiers in Endocrinology, 2023
Graves’ disease (GD) is caused by an autoimmune formation of autoantibodies and autoreactive T-cells against the thyroid stimulating hormone receptor (TSHR).
Anne Gulbins   +3 more
doaj   +3 more sources

Orbital inflammatory disease following mRNA SARS‐CoV‐2 vaccine

open access: yesClinical Case Reports, 2022
A 65‐year‐old woman reported orbital symptoms two days after her first dose and presented exacerbation of signs after the second dose of BNT162b2 mRNA vaccine.
Solange Grunenwald   +4 more
doaj   +1 more source

Magnetic resonance imaging parameters on lacrimal gland in thyroid eye disease: a systematic review and meta-analysis

open access: yesBMC Ophthalmology, 2023
Background Thyroid eye disease is an extrathyroidal manifestation of Graves’ disease and is associated with dry eye disease. This is the first systematic review and meta-analysis to evaluate the role of magnetic resonance imaging lacrimal gland ...
Nicole Tsz Yan Wong   +8 more
doaj   +1 more source

Horizontal eye position in thyroid eye disease: a retrospective comparison with normal individuals and changes after orbital decompression surgery. [PDF]

open access: yesPLoS ONE, 2014
To compare horizontal eye positions between proptotic thyroid eye disease patients and normal individuals, and to examine positional changes after orbital decompression surgery in thyroid eye disease patients.The present case-controlled and retrospective
Yasuhiro Takahashi, Hirohiko Kakizaki
doaj   +1 more source

Dry eye syndrome in thyroid-associated ophthalmopathy

open access: yesOftalʹmologiâ, 2015
Purpose: The pathogenesis of keratoconjunctivitis sicca in patients with thyroid eye disease is presented. The influence of therapy by a HYLO-PARIN® on a condition of a tear film in patients with various forms of thyroid eye disease is assessed. Methods:
A. F. Brovkina   +2 more
doaj   +3 more sources

Identification of optimal surgical plan for treatment of extraocular muscle damage in thyroid eye disease patients based on computational biomechanics

open access: yesFrontiers in Bioengineering and Biotechnology, 2023
This study replicated the behavior of intraorbital tissue in patients with thyroid eye disease (TED) based on finite element analysis for general orbital decompression risk evaluation in thyroid eye disease patients. The orbit and intraorbital tissues of
Byeong Cheol Jeong   +6 more
doaj   +1 more source

Thyroid eye disease or Graves’ orbitopathy: What name to use, and why it matters

open access: yesFrontiers in Endocrinology, 2022
There is currently no universally accepted name for inflammatory disease of the eye and orbit associated with thyroid autoimmune disease. Variability in terminology impedes the evaluation of scientific literature and clinical collaboration and can affect
Lilly H. Wagner   +5 more
doaj   +1 more source

Intraocular pressure improvement in patients receiving teprotumumab for the treatment of thyroid eye disease: a case series

open access: yesJournal of Medical Case Reports, 2022
Background Teprotumumab is a novel treatment that reduces inflammation and symptoms caused by thyroid eye disease. There are limited data on teprotumumab’s effect on intraocular pressure.
Matthew Chu   +4 more
doaj   +1 more source

Morphometric and volumetric analysis of lacrimal glands in patients with thyroid eye disease

open access: yesScientific Reports, 2023
Assessment of morphometric and volumetric changes in lacrimal glands in thyroid eye disease, its clinical manifestations in relation of disease progression.
Ana Starčević   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy